Home > Insider Trading > Filing (0001562180-20-003210)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1434418	Constellation Pharmaceuticals Inc	CNST	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1246842	A Mark Goldsmith	C/O Constellation Pharmaceuticals, Inc. 215 First Street, Suite 200 Cambridge MA 02142		No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-04-27	400	$1.55	143,463	No	4	M	Indirect	Owned by Trusts for which Mark A. Goldsmith is a Trustee
Common Stock	Disposition	2020-04-27	400	$40.12	143,063	No	4	S	Indirect	Owned by Trusts for which Mark A. Goldsmith is a Trustee

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Indirect	Owned by Trusts for which Mark A. Goldsmith is a Trustee
No	4	S	Indirect	Owned by Trusts for which Mark A. Goldsmith is a Trustee

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2020-04-27	400	$0.00	400	$1.55

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
26,850		2021-03-10	No	4	M	Direct

Footnotes

These trades were made pursuant to a Rule 10b5-1 trading plan.
This transaction was executed in multiple trades at prices ranging from $40.03 to $40.16. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Shares are fully vested.